Application 090842
- Type
- ANDA
- Sponsor
- INVAGEN PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RALOXIFENE HYDROCHLORIDE | RALOXIFENE HYDROCHLORIDE | TABLET;ORAL | 60MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090842-001 | RALOXIFENE HYDROCHLORIDE | RALOXIFENE HYDROCHLORIDE | 60MG | TABLET / ORAL | AB | 2014-09-24 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090842-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090842-001 | RALOXIFENE HYDROCHLORIDE | 60MG | TABLET / ORAL | AB | 2014-09-24 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090842-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Raloxifene Hydrochloride | RALOXIFENE | American Health Packaging | f5c25553-1546-451d-8069-c0f484c47741 | 2024-05-13 | Boxed warning, Warnings, Adverse reactions | 090842 ANDA090842 60687-266 |
| Raloxifene Hydrochloride | RALOXIFENE | Aphena Pharma Solutions - Tennessee, LLC | 53a2db10-4af8-4032-b598-b7c7a0969801 | 2021-03-17 | Boxed warning, Warnings, Adverse reactions | 090842 ANDA090842 71610-524 |
| Raloxifene Hydrochloride | RALOXIFENE HYDROCHLORIDE | Exelan Pharmaceuticals, Inc. | 2b94ecf5-d870-4132-b455-d5ee5c9dce56 | 2020-09-30 | Boxed warning, Warnings, Adverse reactions | 090842 ANDA090842 76282-256 |
| Raloxifene Hydrochloride | RALOXIFENE | Cipla USA Inc. | 8fef5bfd-a786-4442-b09b-f3b81812cdac | 2020-09-07 | Boxed warning, Warnings, Adverse reactions | 090842 ANDA090842 69097-825 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0440-5295 | Raloxifene Hydrochloride | Raloxifene Hydrochloride | Liberty Pharmaceuticals, Inc. | ANDA | Current |
| 31722-256 | Raloxifene Hydrochloride | Raloxifene Hydrochloride | Camber Pharmaceuticals Inc | ANDA | Current |
| 50090-5458 | Raloxifene Hydrochloride | Raloxifene | A-S Medication Solutions | ANDA | Current |
| 60687-266 | Raloxifene Hydrochloride | Raloxifene | American Health Packaging | ANDA | Current |
| 60687-266 | Raloxifene Hydrochloride | Raloxifene | American Health Packaging | ANDA | Current |
| 60687-266 | Raloxifene Hydrochloride | Raloxifene | American Health Packaging | ANDA | Current |
| 60687-266 | Raloxifene Hydrochloride | Raloxifene | American Health Packaging | ANDA | Current |
| 60687-266 | Raloxifene Hydrochloride | Raloxifene | American Health Packaging | ANDA | Current |
| 63629-7708 | Raloxifene Hydrochloride | Raloxifene | Bryant Ranch Prepack | ANDA | Current |
| 63629-7708 | Raloxifene Hydrochloride | Raloxifene | Bryant Ranch Prepack | ANDA | Current |
| 69097-825 | Raloxifene Hydrochloride | Raloxifene | Cipla USA Inc. | ANDA | Current |
| 69097-825 | Raloxifene Hydrochloride | Raloxifene | Cipla USA Inc. | ANDA | Current |
| 69097-825 | Raloxifene Hydrochloride | Raloxifene | Cipla USA Inc. | ANDA | Current |
| 70518-3046 | Raloxifene Hydrochloride | Raloxifene | REMEDYREPACK INC. | ANDA | Current |
| 71335-1663 | Raloxifene Hydrochloride | Raloxifene | Bryant Ranch Prepack | ANDA | Current |
| 71335-1663 | Raloxifene Hydrochloride | Raloxifene | Bryant Ranch Prepack | ANDA | Current |
| 71610-524 | Raloxifene Hydrochloride | Raloxifene | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 76282-256 | Raloxifene Hydrochloride | Raloxifene Hydrochloride | Exelan Pharmaceuticals, Inc. | ANDA | Current |
| 76282-256 | Raloxifene Hydrochloride | Raloxifene Hydrochloride | Exelan Pharmaceuticals, Inc. | ANDA | Current |
| 76282-256 | Raloxifene Hydrochloride | Raloxifene Hydrochloride | Exelan Pharmaceuticals, Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 54299 | ORIG | 2018-05-22 |